Pharmaceutical composition comprising nanoperforator for preventing or treating viral infectious diseases
US11541100B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2017 |
| Grant date | Jan 3, 2023 |
| Priority date | — |
| Expiry date | Dec 8, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2405/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a nanoperforator having a lipid-bilayer nanodisc and a membrane-structured protein surrounding the nanodisc and to a pharmaceutical composition having the nanoperforator as an active ingredient for preventing or treating viral infectious diseases. The use of the lipid-bilayer nanoperforator provided in the present invention can lead to the safe prevention or treatment of a disease caused by viral infection regardless of whether the virus is a variant or not, and thus the present invention can be widely used for the safe and effective treatment of viral infectious diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.